Markets

Friday 7/5 Insider Buying Report: BBIO, CHNG

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys.

On Monday, Bridgebio Pharma's, Michael Thomas Henderson, made a $119,000 buy of BBIO, purchasing 7,000 shares at a cost of $17.00 a piece. Henderson was up about 69.4% on the purchase at the high point of today's trading session, with BBIO trading as high as $28.80 in trading on Friday. Bridgebio Pharma is trading down about 3% on the day Friday. This purchase marks the first one filed by Henderson in the past twelve months.

And also on Monday, Director Bansi Nagji bought $65,000 worth of Change Healthcare, buying 5,000 shares at a cost of $13.00 a piece. This purchase marks the first one filed by Nagji in the past twelve months. Change Healthcare is trading up about 0.7% on the day Friday. So far Nagji is in the green, up about 16.5% on their purchase based on today's trading high of $15.15.

VIDEO: Friday 7/5 Insider Buying Report: BBIO, CHNG

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BBIO CHNG

Other Topics

Stocks

Latest Markets Videos